Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cynthia Collins currently holds 49,579 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cynthia Collins has been a net seller of PSTX stock. They have purchased $0 and sold $299.4K worth of shares.
Cynthia Collins's most recent insider trade was on Jun 17, 2026, when they sold 49,579 shares at $0.00 per share.
Cynthia Collins serves as Executive at Poseida Therapeutics, Inc. (PSTX). They have executed 48 insider transactions totaling $299.4K over their tenure at the company.
Cynthia Collins holds the position of Executive at Poseida Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Cynthia Collins has shown a selling trading pattern, with $0 in total purchases and $299.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cynthia Collins was on Jun 30, 2011, when they sold $1.3M worth of BEC shares. This transaction involved 15,043 shares at $83.50 per share.
Cynthia Collins currently owns 49,579 shares of Poseida Therapeutics, Inc. (PSTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cynthia Collins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cynthia Collins has 48 Form 4 filings on record as an insider at Poseida Therapeutics, Inc..
Set alerts for Cynthia Collins and 40,000+ other insiders.